CA2064710A1 - Recombinant protein which binds to a complex viral antigen of hiv-1 - Google Patents
Recombinant protein which binds to a complex viral antigen of hiv-1Info
- Publication number
- CA2064710A1 CA2064710A1 CA002064710A CA2064710A CA2064710A1 CA 2064710 A1 CA2064710 A1 CA 2064710A1 CA 002064710 A CA002064710 A CA 002064710A CA 2064710 A CA2064710 A CA 2064710A CA 2064710 A1 CA2064710 A1 CA 2064710A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- sc3d6
- ser
- val
- stated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/112—Retroviridae (F), e.g. leukemia viruses
- C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
- C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA1178/90 | 1990-05-29 | ||
| AT0117890A AT396939B (de) | 1990-05-29 | 1990-05-29 | Komplexes virales antigen von hiv-1 bindendes rekombinantes protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2064710A1 true CA2064710A1 (en) | 1991-11-30 |
Family
ID=3508299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002064710A Abandoned CA2064710A1 (en) | 1990-05-29 | 1991-05-28 | Recombinant protein which binds to a complex viral antigen of hiv-1 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0484500A1 (de) |
| JP (1) | JPH05501062A (de) |
| AT (1) | AT396939B (de) |
| CA (1) | CA2064710A1 (de) |
| SK (1) | SK160391A3 (de) |
| WO (1) | WO1991018983A1 (de) |
| YU (1) | YU114691A (de) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440189B2 (en) | 1999-01-15 | 2013-05-14 | Biogen Idec Ma Inc. | Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| US8728475B2 (en) | 2005-05-10 | 2014-05-20 | Biogen Idec Ma Inc. | Methods for treating inflammatory bowel disease |
| US9011859B2 (en) | 2002-04-09 | 2015-04-21 | Biogen Idec Ma Inc. | Methods for treating TWEAK-related conditions |
| US9730947B2 (en) | 2005-06-13 | 2017-08-15 | Biogen Ma Inc. | Method of treating lupus nephritis |
| US9775899B2 (en) | 2005-02-17 | 2017-10-03 | Biogen Ma Inc. | Treating neurological disorders |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU655878B2 (en) * | 1992-03-30 | 1995-01-12 | Daiichi Suntory Pharma Co., Ltd | Anti-HBs antibody gene and expression plasmid thereof |
| WO1994026895A1 (fr) * | 1993-05-10 | 1994-11-24 | Japan Tobacco Inc. | Gene vh d'immunoglobuline humaine et fragment d'adn contenant ce gene |
| US6936705B1 (en) | 1993-05-10 | 2005-08-30 | Japan Tobacco Inc. | Human immunoglobulin VH gene segments and DNA fragments containing the same |
| US6096878A (en) * | 1993-05-10 | 2000-08-01 | Japan Tobacco Inc. | Human immunoglobulin VH gene segments and DNA fragments containing the same |
| AU2001245815A1 (en) * | 2000-03-15 | 2001-09-24 | Incyte Genomics, Inc. | Human immune response proteins |
| MEP35408A (en) * | 2005-05-27 | 2011-02-10 | Biogen Idec Inc | Tweak binding antibodies |
| JP2010528583A (ja) * | 2007-06-11 | 2010-08-26 | エーシー イミューン ソシエテ アノニム | アミロイドβに対するヒト化抗体 |
| US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| AU2008311367B2 (en) | 2007-10-05 | 2014-11-13 | Ac Immune S.A. | Use of anti-amyloid beta antibody in ocular diseases |
| SG190572A1 (en) | 2008-04-29 | 2013-06-28 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| TW201006485A (en) | 2008-06-03 | 2010-02-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| WO2011028811A2 (en) | 2009-09-01 | 2011-03-10 | Abbott Laboratories | Dual variable domain immunoglobulins and uses thereof |
| BR112012008833A2 (pt) | 2009-10-15 | 2015-09-08 | Abbott Lab | imunoglobulinas de dominio variavel duplo e usos das mesmas |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| EP2598882B1 (de) | 2010-07-30 | 2017-07-26 | AC Immune S.A. | Sichere und funktionelle humanisierte antikörper für die verwendung in der behandlung von einer amyloidose |
| EP3252072A3 (de) | 2010-08-03 | 2018-03-14 | AbbVie Inc. | Immunglobuline mit zweifacher variabler domäne und verwendungen davon |
| JP2013539364A (ja) | 2010-08-26 | 2013-10-24 | アッヴィ・インコーポレイテッド | 二重可変ドメイン免疫グロブリンおよびその使用 |
| TW201333035A (zh) | 2011-12-30 | 2013-08-16 | Abbvie Inc | 針對il-13及/或il-17之雙特異性結合蛋白 |
| TW202037609A (zh) | 2012-11-01 | 2020-10-16 | 美商艾伯維有限公司 | 抗-vegf/dll4雙重可變區域免疫球蛋白及其用途 |
| WO2014144280A2 (en) | 2013-03-15 | 2014-09-18 | Abbvie Inc. | DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1β AND / OR IL-17 |
| US10093733B2 (en) | 2014-12-11 | 2018-10-09 | Abbvie Inc. | LRP-8 binding dual variable domain immunoglobulin proteins |
| TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗vegf、pdgf及/或其受體之結合蛋白 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851341A (en) * | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
| PT88641B (pt) * | 1987-10-02 | 1993-04-30 | Genentech Inc | Metodo para a preparacao de uma variante de adesao |
| EP0312164A1 (de) * | 1987-10-16 | 1989-04-19 | Merck & Co. Inc. | Reinigung von rekombinanten Epstein-Barr-Virusantigenen von Vero-, Hefe- oder L-Zellen |
| JPH02502251A (ja) * | 1987-11-13 | 1990-07-26 | ヘルマン カーティンガー | ヒトのモノクローン性抗hiv‐1‐抗体 |
-
1990
- 1990-05-29 AT AT0117890A patent/AT396939B/de not_active IP Right Cessation
-
1991
- 1991-05-28 WO PCT/AT1991/000067 patent/WO1991018983A1/de not_active Ceased
- 1991-05-28 CA CA002064710A patent/CA2064710A1/en not_active Abandoned
- 1991-05-28 EP EP91910271A patent/EP0484500A1/de not_active Withdrawn
- 1991-05-28 YU YU114691A patent/YU114691A/sh unknown
- 1991-05-28 JP JP3509464A patent/JPH05501062A/ja active Pending
- 1991-05-29 SK SK1603-91A patent/SK160391A3/sk unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8440189B2 (en) | 1999-01-15 | 2013-05-14 | Biogen Idec Ma Inc. | Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| US9011859B2 (en) | 2002-04-09 | 2015-04-21 | Biogen Idec Ma Inc. | Methods for treating TWEAK-related conditions |
| US9775899B2 (en) | 2005-02-17 | 2017-10-03 | Biogen Ma Inc. | Treating neurological disorders |
| US8728475B2 (en) | 2005-05-10 | 2014-05-20 | Biogen Idec Ma Inc. | Methods for treating inflammatory bowel disease |
| US9730947B2 (en) | 2005-06-13 | 2017-08-15 | Biogen Ma Inc. | Method of treating lupus nephritis |
Also Published As
| Publication number | Publication date |
|---|---|
| YU114691A (sh) | 1994-06-10 |
| AT396939B (de) | 1993-12-27 |
| WO1991018983A1 (de) | 1991-12-12 |
| SK160391A3 (en) | 1995-07-11 |
| EP0484500A1 (de) | 1992-05-13 |
| ATA117890A (de) | 1993-05-15 |
| JPH05501062A (ja) | 1993-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2064710A1 (en) | Recombinant protein which binds to a complex viral antigen of hiv-1 | |
| EP0199301B2 (de) | Rekombinantes Viren-Überzugsprotein assoziiert mit "Acquired Immune Deficiency Syndrome" (AIDS) und Verfahren zur Testung von AIDS | |
| KR950008570B1 (ko) | 임파선중 관련 바이러스(lav)의 코어 단백질 인식용 단일 클론 항체가 인식하는 폴리펩타이드의 정제 방법과 그러한 항체를 분비하는 하이브리도마의 제조방법 | |
| KR20050108389A (ko) | 모노클로날 항체 및 이것을 생산하는 하이브리도마 | |
| NO870027L (no) | Ekspresjon av htlv-iii gag-gen. | |
| JPH02107196A (ja) | 抗HIV―1p24マウスモノクローナル抗体、その産生細胞株およびそれを用いたイムノアッセイ法 | |
| EP0540586A1 (de) | Bindungsdomäne | |
| WO1991009872A2 (en) | Hiv-1 env fragment fusion protein | |
| NO300462B1 (no) | Monoklonale antistoffer og peptider som kan anvendes til diagnose av HIV-infeksjoner | |
| CA2028172A1 (en) | Synthetic envelope peptides of htlv-i | |
| US6171596B1 (en) | Oligomeric HIV-1 envelope glycoproteins | |
| CN112626033A (zh) | Irg1单克隆抗体及其制备方法和用途 | |
| CA1340878C (en) | Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies | |
| KR102453605B1 (ko) | 신규 펩타이드 태그, 이에 결합하는 항체 및 이들의 용도 | |
| JPH06510790A (ja) | 分泌Mac−2結合糖タンパク質 | |
| CN117777283A (zh) | 一种牛白血病病毒p24蛋白的单克隆抗体及其应用 | |
| WO2023068377A1 (ja) | SARS-CoV-2のORF8タンパク質に結合するモノクローナル抗体及び該抗体を含む炎症抑制組成物 | |
| Park et al. | Characterization and gene cloning of monoclonal antibody specific for the hepatitis B virus X protein | |
| CN110078820A (zh) | 牛白血病病毒抗体及检测试剂盒 | |
| CN116284352A (zh) | 牛白血病病毒抗体及检测试剂盒 | |
| US6039957A (en) | Oligomeric HIV-1 envelope glycoproteins | |
| CN116063476B (zh) | 一种马尔尼菲篮状菌colp6的单克隆抗体A7及其制备方法和应用 | |
| CN110483641B (zh) | 干扰素诱导型gtp酶的单克隆抗体及其应用 | |
| CN111349169B (zh) | Werner综合征ATP依赖性解旋酶的单克隆抗体及其应用 | |
| CN115925915A (zh) | 一种马尔尼菲篮状菌colp6的单克隆抗体A5及其制备方法和应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |